Brief: Sequana Medical Confirms Prior DSR® Therapy Data

Sequana Medical NV

25/03/2024 06:04

March 25 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * THREE MONTH FOLLOW-UP DATA FROM MOJAVE NON-RANDOMIZED
COHORT
CONFIRMING DRAMATIC IMPROVEMENT IN DIURETIC RESPONSE AND VIRTUAL
ELIMINATION OF LOOP DIURETICS FOLLOWING DSR® THERAPY
    * PREVIOUSLY REPORTED STRONG DATA MAINTAINED AFTER
THREE-MONTHS
FOLLOW-UP: * DIURETIC RESPONSE REMAINED NEARLY NORMALIZED, WITH
A MEAN INCREASE OF 326% IN SIX-HOUR URINARY SODIUM EXCRETION
VERSUS BASELINE
    * ALL THREE PATIENTS REMAINED ON NO OR LOW DOSE LOOP
DIURETICS,
WITH A REDUCTION OF AT LEAST 95% VERSUS BASELINE
    * RANDOMIZED COHORT OF UP TO 30 ADDITIONAL PATIENTS PLANNED
TO
COMMENCE FOLLOWING US MARKET APPROVAL OF ALFAPUMP®

Source text for Eikon:  ID:nGNX76hckf 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))